Shionogi seeks Japan approval for COVID-19 vaccine




  • In US
  • 2022-11-24 04:17:49Z
  • By Reuters

TOKYO (Reuters) - Shionogi & Co Ltd said on Thursday it had filed for approval in Japan of its experimental COVID-19 vaccine.

The move comes two days after Japanese regulators granted emergency approval for Shionogi's oral treatment for COVID, the first for a domestic drugmaker.

The filing for the recombinant protein-based vaccine, known as S-268019, was based on results from five clinical trials in Japan, Shionogi said in a statement.

The company seeks to market the shot as a primary vaccine and booster against the coronavirus.

The drugmaker's stock surged in early trade before paring gains on the first trading day since the approval of its COVID pill.

Regulators in Japan had previously denied emergency approval for the drug, a protease inhibitor known as ensitrelvir, saying they wanted to see more data on its effectiveness. There were also concerns that the drug could pose a risk to pregnancies, based on results from animal studies.

Shionogi last month raised its full-year sales forecast on expectations that it would win regulatory approval. The company has signed an agreement to sell about a million doses to the Japanese government, pending approval, and has received U.S. government funding for a global trial.

The pill would compete with oral COVID-19 treatments developed by Pfizer Inc and Merck & Co which have already been approved in Japan.

Shionogi shares were up 0.6% in Tokyo, compared to a 1.1% advance in the benchmark Nikkei gauge. The stock earlier surged as much as 5.9%.

(Reporting by Rocky Swift; Editing by Rashmi Aich)

COMMENTS

More Related News

Protests erupt in Xinjiang and Beijing after deadly fire
Protests erupt in Xinjiang and Beijing after deadly fire
  • US
  • 2022-11-26 07:46:09Z

Public anger in China towards widening COVID-19 lockdowns across the country erupted into rare protests in China's far western Xinjiang region and the...

Panic Buying in Beijing as Covid Surge Spurs Creeping Restrictions
Panic Buying in Beijing as Covid Surge Spurs Creeping Restrictions

(Bloomberg) -- Beijing's streets are deserted and grocery delivery services are running out of capacity as rising Covid cases trigger lockdown-like...

Global shares mixed as investors eye China virus crisis
Global shares mixed as investors eye China virus crisis
  • US
  • 2022-11-25 07:01:49Z

Global shares were mixed Friday as worries deepened about the regional economy and Japan reported higher-than-expected inflation. Britain's FTSE 100 gained ...

Tokyo Inflation Hits Fastest Pace Since 1982, Fueled by Weak Yen
Tokyo Inflation Hits Fastest Pace Since 1982, Fueled by Weak Yen

(Bloomberg) -- Tokyo's inflation outpaced forecasts to hit its fastest clip since 1982, an acceleration that suggests nationwide price growth will also...

Consumer inflation in Japan
Consumer inflation in Japan's capital rises at fastest pace in 40 years

TOKYO (Reuters) -Core consumer prices in Japan's capital, considered a leading indicator of nationwide trends, rose 3.6% in November from a year earlier...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US